New Molecular Targets for Cancer Chemotherapy
This book covers a wide range of novel biochemical targets that appear to be the best leads in terms of designing novel targets for anticancer drug design. New Molecular Targets for Cancer Chemotherapy is a unique, multi-disciplinary effort, with internationally respected authors from the fields of growth factor-receptor interaction, phosphoinositide and phospholipase signal transduction, and DNA-drug binding interactions. The science is placed in clinical context and illustrations explain how clinicians can incorporate a mechanistic, pharmacodynamic approach into early clinical trial design.
What people are saying - Write a review
We haven't found any reviews in the usual places.
3T3 cells Acad agents amino acids analogues antibodies anticancer antisense antitumor apoptosis binding Biochem Biol blockers bombesin c-erbB2 cancer cells Cancer Res carcinoma cell cycle cell death cell lines cellular Chem complex compounds cytotoxic diacylglycerol differentiation domain drug effects EGF receptor EGFR endonuclease enzyme epidermal growth factor expression fibroblasts function growth factor receptor GTPase H]vinblastine human hydrolysis increase induced inhibition inhibitors inositol interaction intracellular involved isoforms leukemia ligand lipid malignant MAP kinase mechanism membrane mitogenic molecular molecule mutation myo-inositol Natl NIH 3T3 normal nucleotide oligonucleotides oncogene overexpression P-gp PDGF phenotype phorbol esters phosphatidylinositol phospholipase phosphorylation PKC activity potential Proc protein kinase proto-oncogene PtdInsPLC Ras proteins regulation response role sequence SH2 domain signal transduction signaling pathways specific staurosporine stimulation structure studies substrate suppressor genes Swiss 3T3 synthesis target therapeutic therapy toxicity transcription factors transformation tumor cells tyrosine phosphorylation tyrphostins vitro wild-type